Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
|Articles|January 15, 2014
Equipment and Processing Report
- Equipment and Processing Report-01-15-2014
- Volume 0
- Issue 0
Volkmann Introduces Low-Profile Pneumatic Conveyor
A low-profile pneumatic pharmaceutical conveyor moves tablets and capsules in restricted height areas.
Low-profile models in Volkmann’s pneumatic pharmaceutical conveyor series (PPCVS) feature a low-profile vacuum pump and reverse-jet shock tank to convey tablets and capsules in restricted height areas. All Volkmann PPCVS units feature a one-piece, gap-free design with a smooth, polished stainless-steel surface. A modular, quick-release, cGMP design allows for no-tools cleaning. The units feature a patented QX filter system with a unique connection to the filter plate. In this design, a double seal replaces the commonly used felt seal or O-ring seal and ensures complete isolation of the process down to 0.3 micron.
Source:
Articles in this issue
almost 13 years ago
Accelrys Materials Studio Enhances Modeling and Simulationalmost 13 years ago
2014 Manufacturing Trends and Outlookalmost 13 years ago
Selecting Single-Use Systems for Biopharmaceutical Manufacturingalmost 13 years ago
Preparing for Serialization: A Q&A with Packaging Coordinators, Inc.Related to this article
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Terry Katz, CEO and cofounder of ForgeStop Technology Corporation, explains the company’s CPHI Award-winning connected product technology and how it helps to combat drug counterfeiting.
Bettina Brierley, chief commercial officer at Celtic Renewables, discusses commercialization of biosolvents for pharmaceutical manufacturing.
Coverage from AAPS PharmSci 360 and CPHI Milan featured discussion about impurities, devices, and supply resilience. This week also included topics such as AI accountability, oral peptides, and new licensing deals.
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
Onshoring pharmaceutical manufacturing can be made more practical by collaborating with CDMOs that have gray space, supported by strong relationships with used equipment dealers and OEMs.
USP data show fewer US drug shortages but longer ones, averaging 5+ years. Drug shortages are an incentive problem, not a manufacturing mystery.
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
Our Biggest Takeaways From AAPS PharmSci 360
3
$1.15B AI-Guided Macrocycle Discovery Lands at argenx
4
The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites
5